PofoliaShared via Pofolia

Drug Design Development and Therapy· 2026Q1· Review

Apigenin: Antihypertensive Effects and Underlying Mechanisms — A Comprehensive Review

Xiaolin Liao, Hangxing Huang, Junlong Cai, Huaguan Lu et al.

Short summary

Apigenin, a dietary flavone, demonstrates antihypertensive effects via four core pathways, but its poor solubility hinders oral bioavailability and clinical translation.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Apigenin exhibits multi-target hypotensive effects through four identified core antihypertensive pathways.
  • Poor water solubility is a major limitation for apigenin's oral bioavailability and industrial use.
  • Current human evidence for apigenin's antihypertensive efficacy is limited, relying on crude extracts rather than purified compound.
  • Strategies like food-grade nanoformulation and standardized clinical trials are proposed to overcome translational bottlenecks.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract: Apigenin, a ubiquitous dietary flavone from vegetables, fruits and herbal teas, exhibits multi-target hypotensive effects, yet its poor water solubility limits oral bioavailability and industrial translation. Previous reviews only summarized its general bioactivities and anti-atherosclerotic effects, without comprehensively analyzing its antihypertensive mechanisms. Most evidence derives from preclinical studies; human trials merely use crude celery seed extracts instead of purified apigenin, lacking reliable clinical proof for its antihypertensive efficacy. This review summarizes apigenin’s sources, chemical properties, safety and solubility-enhanced delivery systems to support functional food exploitation. We elaborate four core antihypertensive pathways, and also point out translational bottlenecks and propose strategies including food-grade nanoformulation and standardized clinical trials. This work links preclinical mechanisms to food industry application, providing theoretical evidence for developing apigenin-enriched functional foods for hypertension adjuvant intervention. Keywords: apigenin, hypertension, antioxidant, anti-inflammation, blood pressure, flavone

The authors' abstract, as published at the source. Drug Design Development and Therapy, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Pharmacology (Medicine)

PharmacologyMedicine